|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.59 USD | +0.35% |
|
-2.98% | -4.83% |
| Market Cap | 4.37B 3.82B 3.53B 3.26B 6.14B 419B 6.25B 42.07B 16.5B 205B 16.4B 16.04B 707B | P/E 2026 * |
66.3x | P/E 2027 * | 34.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.4B 2.97B 2.75B 2.54B 4.78B 327B 4.87B 32.77B 12.86B 160B 12.78B 12.5B 551B | EV / Sales 2026 * |
2.74x | EV / Sales 2027 * | 2.29x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +0.12% | ||
| 1 week | -2.98% | ||
| Current month | +0.47% | ||
| 1 month | +19.54% | ||
| 3 months | +15.44% | ||
| 6 months | -5.36% | ||
| Current year | -4.83% |
| 1 week | 24.95 |  | 26.51 |
| 1 month | 20.84 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 05-29 | Baker Bros. Advisors LP
| Free | Company | 101,260 | 0.0591% | |
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.35% | -2.98% | +16.13% | -21.01% | 4.37B | |
| -1.05% | +1.39% | +3.15% | +6.98% | 50.61B | |
| +0.45% | -2.95% | +381.73% | +593.32% | 39.11B | |
| +0.33% | -0.35% | +29.58% | -6.15% | 34.64B | |
| +0.76% | -0.74% | +21.63% | +56.20% | 33.79B | |
| -1.31% | -1.76% | +1.59% | +27.01% | 26.89B | |
| +0.38% | -0.08% | - | - | 16.47B | |
| +1.56% | -1.61% | +67.78% | +121.01% | 15.14B | |
| -0.72% | +0.12% | +14.69% | +16.95% | 13.85B | |
| +1.63% | -0.15% | +12.67% | -31.59% | 12.72B | |
| Average | +0.22% | -1.49% | +61.00% | +84.75% | 24.76B | |
| Weighted average by Cap. | +0.06% | -1.14% | +79.39% | +119.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.08B 1B 926M 1.74B 119B 1.78B 11.95B 4.69B 58.36B 4.66B 4.56B 201B | 1.4B 1.22B 1.13B 1.04B 1.96B 134B 2B 13.44B 5.27B 65.62B 5.24B 5.13B 226B |
| Net income | 65.75M 57.46M 53.12M 49.08M 92.42M 6.32B 94.09M 633M 249M 3.09B 247M 242M 10.65B | 134M 117M 108M 99.83M 188M 12.85B 191M 1.29B 506M 6.29B 502M 491M 21.66B |
| Net Debt | -965M -843M -779M -720M -1.36B -92.65B -1.38B -9.29B -3.65B -45.37B -3.62B -3.54B -156B | -1.18B -1.03B -951M -879M -1.65B -113B -1.68B -11.34B -4.45B -55.37B -4.42B -4.32B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | $25.44 | -0.24% | 525,945 |
| 13/07/26 | $25.50 | -2.75% | 1,562,833 |
| 10/07/26 | $26.22 | -0.72% | 1,442,787 |
| 09/07/26 | $26.41 | +1.58% | 1,801,279 |
| 08/07/26 | $26.00 | -0.76% | 1,551,853 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
